Table 1.
Relationship between tyrosine‐activated Stat3 (pStat3) immunoreactivity of tumour and pathological features of human epithelial ovarian carcinoma
| Characteristic | n (%） | pStat3 nuclear expression | χ2 | P value | |
|---|---|---|---|---|---|
| Low | High | ||||
| Age (y) | 156 | 2.988 | 0.084 | ||
| ≤50 | 64 (41.03) | 34 | 30 | ||
| >50 | 92 (58.97) | 36 | 56 | ||
| Tumour grade | 156 | 0.943 | 0.624 | ||
| G1 | 27 (17.3) | 11 | 16 | ||
| G2 | 37 (23.7) | 18 | 19 | ||
| G3 | 84 (53.8) | 33 | 51 | ||
| Disease stage | 156 | 3.299 | 0.348 | ||
| Stage I | 9 (5.8) | 5 | 4 | ||
| Stage II | 37 (23.7) | 17 | 20 | ||
| Stage III | 78 (50.0) | 38 | 40 | ||
| Stage IV | 32 (20.5) | 10 | 22 | ||
| Histotype | 156 | 8.045 | 0.045 | ||
| Serious carcinoma | 116 (74.4) | 46 | 70 | ||
| Mucinous adenocarcinoma | 22 (14.1) | 14 | 8 | ||
| Endometrioid adenocarcinoma | 12 (7.7) | 5 | 7 | ||
| Other subtypes | 6 (3.8) | 5 | 1 | ||
| Diameter of primary focus (cm) | 156 | 6.332 | 0.012 | ||
| <10 cm | 61 (39.1) | 35 | 26 | ||
| ≥10 cm | 95 (60.9) | 35 | 60 | ||
| Lymph node metastasis | 156 | 2.394 | 0.122 | ||
| N0 | 113 (72.4) | 55 | 58 | ||
| N1 | 43 (27.6) | 15 | 28 | ||
| Distant metastasis | 156 | 0.180 | 0.672 | ||
| M0 | 111 (71.2) | 51 | 60 | ||
| M1 | 45 (28.8) | 19 | 26 | ||
| Progressive disease | 156 | 9.441 | 0.002 | ||
| No recurrence | 72 (46.2) | 37 | 35 | ||
| Recurrence | 84 (53.8) | 23 | 61 | ||
Boldface indicates P < .05.